 Megan Wilson
Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Altitude | 18 | 2014 | 409 | 1.470 |
Why?
| | Selection, Genetic | 5 | 2013 | 243 | 0.520 |
Why?
| | Uterus | 3 | 2009 | 193 | 0.410 |
Why?
| | Adaptation, Physiological | 4 | 2013 | 476 | 0.400 |
Why?
| | Fetal Growth Retardation | 7 | 2011 | 466 | 0.380 |
Why?
| | Birth Weight | 8 | 2014 | 440 | 0.360 |
Why?
| | Uterine Artery | 5 | 2014 | 67 | 0.340 |
Why?
| | Altitude Sickness | 4 | 2013 | 152 | 0.290 |
Why?
| | Acclimatization | 4 | 2013 | 132 | 0.280 |
Why?
| | Pregnancy | 12 | 2014 | 5553 | 0.270 |
Why?
| | Bolivia | 9 | 2014 | 61 | 0.260 |
Why?
| | Fetal Development | 4 | 2013 | 247 | 0.240 |
Why?
| | Hypoxia | 5 | 2013 | 937 | 0.210 |
Why?
| | Regional Blood Flow | 4 | 2011 | 428 | 0.170 |
Why?
| | Vascular Resistance | 2 | 2011 | 338 | 0.150 |
Why?
| | Tibet | 3 | 2013 | 27 | 0.140 |
Why?
| | Oxygen | 3 | 2011 | 837 | 0.140 |
Why?
| | Infant, Small for Gestational Age | 3 | 2011 | 76 | 0.130 |
Why?
| | Hemoglobins | 3 | 2013 | 312 | 0.120 |
Why?
| | Indians, South American | 3 | 2013 | 22 | 0.120 |
Why?
| | Enzymes | 2 | 2013 | 61 | 0.120 |
Why?
| | Acetazolamide | 2 | 2011 | 29 | 0.120 |
Why?
| | Receptor, Endothelin A | 1 | 2014 | 59 | 0.120 |
Why?
| | Gestational Age | 6 | 2014 | 758 | 0.120 |
Why?
| | Gene Frequency | 2 | 2014 | 485 | 0.110 |
Why?
| | AMP-Activated Protein Kinases | 1 | 2014 | 175 | 0.110 |
Why?
| | Hypertension, Pregnancy-Induced | 2 | 2011 | 45 | 0.110 |
Why?
| | Polymorphism, Single Nucleotide | 4 | 2014 | 1919 | 0.110 |
Why?
| | Europe | 3 | 2009 | 336 | 0.100 |
Why?
| | Genetics, Population | 2 | 2010 | 192 | 0.100 |
Why?
| | Dexamethasone | 2 | 2011 | 316 | 0.100 |
Why?
| | Pregnancy Outcome | 2 | 2011 | 337 | 0.100 |
Why?
| | Blood Proteins | 1 | 2013 | 238 | 0.100 |
Why?
| | Antioxidants | 2 | 2013 | 533 | 0.100 |
Why?
| | Pre-Eclampsia | 2 | 2011 | 165 | 0.100 |
Why?
| | Hypoxia, Brain | 1 | 2011 | 8 | 0.100 |
Why?
| | Cell Membrane Permeability | 1 | 2011 | 83 | 0.090 |
Why?
| | Homeostasis | 1 | 2014 | 577 | 0.090 |
Why?
| | Angiostatic Proteins | 1 | 2010 | 5 | 0.090 |
Why?
| | Angiogenic Proteins | 1 | 2010 | 18 | 0.090 |
Why?
| | Delivery, Obstetric | 2 | 2011 | 119 | 0.090 |
Why?
| | Infant, Low Birth Weight | 1 | 2011 | 125 | 0.090 |
Why?
| | Infant, Newborn | 6 | 2013 | 5061 | 0.090 |
Why?
| | Genotype | 2 | 2014 | 1787 | 0.090 |
Why?
| | Adult | 14 | 2014 | 30789 | 0.090 |
Why?
| | Databases, Genetic | 1 | 2010 | 208 | 0.080 |
Why?
| | Cerebrovascular Circulation | 1 | 2011 | 203 | 0.080 |
Why?
| | Basic Helix-Loop-Helix Transcription Factors | 1 | 2011 | 225 | 0.080 |
Why?
| | Women's Health | 1 | 2011 | 271 | 0.080 |
Why?
| | Fertility | 1 | 2009 | 131 | 0.080 |
Why?
| | Genome, Human | 1 | 2010 | 352 | 0.080 |
Why?
| | Interleukin-1beta | 1 | 2010 | 370 | 0.080 |
Why?
| | Proteomics | 1 | 2013 | 859 | 0.070 |
Why?
| | Blood Volume | 1 | 2007 | 58 | 0.070 |
Why?
| | Biometry | 1 | 2007 | 63 | 0.070 |
Why?
| | Arteries | 1 | 2009 | 250 | 0.070 |
Why?
| | Fetal Hypoxia | 1 | 2007 | 47 | 0.070 |
Why?
| | Endothelin-1 | 1 | 2008 | 167 | 0.070 |
Why?
| | Geography | 3 | 2011 | 181 | 0.070 |
Why?
| | Genomics | 1 | 2011 | 646 | 0.070 |
Why?
| | Female | 15 | 2014 | 60018 | 0.060 |
Why?
| | Biological Evolution | 1 | 2009 | 417 | 0.060 |
Why?
| | Humans | 19 | 2014 | 115741 | 0.060 |
Why?
| | Indians, North American | 1 | 2009 | 584 | 0.060 |
Why?
| | Gene Expression Profiling | 1 | 2010 | 1537 | 0.060 |
Why?
| | Lower Extremity | 1 | 2007 | 337 | 0.060 |
Why?
| | Gene Expression Regulation | 1 | 2013 | 2353 | 0.060 |
Why?
| | Nitric Oxide | 1 | 2008 | 832 | 0.050 |
Why?
| | Cytokines | 1 | 2010 | 1853 | 0.050 |
Why?
| | South America | 2 | 2013 | 53 | 0.050 |
Why?
| | Inflammation | 1 | 2011 | 2500 | 0.050 |
Why?
| | Ultrasonography, Prenatal | 2 | 2013 | 235 | 0.050 |
Why?
| | Case-Control Studies | 3 | 2013 | 3037 | 0.040 |
Why?
| | Acute Disease | 2 | 2013 | 914 | 0.040 |
Why?
| | Blood Flow Velocity | 2 | 2011 | 382 | 0.040 |
Why?
| | Double-Blind Method | 2 | 2011 | 1660 | 0.030 |
Why?
| | Young Adult | 4 | 2011 | 10518 | 0.030 |
Why?
| | Receptor, Endothelin B | 1 | 2014 | 51 | 0.030 |
Why?
| | Receptors, Endothelin | 1 | 2014 | 49 | 0.030 |
Why?
| | Body Weights and Measures | 1 | 2013 | 32 | 0.030 |
Why?
| | Gene Regulatory Networks | 1 | 2014 | 231 | 0.030 |
Why?
| | Genetic Association Studies | 1 | 2014 | 345 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2014 | 4448 | 0.030 |
Why?
| | Biomarkers | 2 | 2013 | 3471 | 0.030 |
Why?
| | Time Factors | 2 | 2013 | 6171 | 0.030 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2013 | 477 | 0.020 |
Why?
| | Linear Models | 1 | 2014 | 778 | 0.020 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2014 | 362 | 0.020 |
Why?
| | Carbonic Anhydrase Inhibitors | 1 | 2011 | 16 | 0.020 |
Why?
| | Apgar Score | 1 | 2011 | 16 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2013 | 414 | 0.020 |
Why?
| | Colorado | 2 | 2013 | 4116 | 0.020 |
Why?
| | Mountaineering | 1 | 2011 | 45 | 0.020 |
Why?
| | Laser-Doppler Flowmetry | 1 | 2011 | 32 | 0.020 |
Why?
| | Brain Edema | 1 | 2011 | 59 | 0.020 |
Why?
| | Live Birth | 1 | 2011 | 48 | 0.020 |
Why?
| | Iliac Artery | 1 | 2011 | 44 | 0.020 |
Why?
| | Globins | 1 | 2010 | 22 | 0.020 |
Why?
| | Procollagen-Proline Dioxygenase | 1 | 2010 | 26 | 0.020 |
Why?
| | Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2010 | 20 | 0.020 |
Why?
| | Stillbirth | 1 | 2011 | 57 | 0.020 |
Why?
| | Placenta Growth Factor | 1 | 2010 | 23 | 0.020 |
Why?
| | Prospective Studies | 2 | 2013 | 6276 | 0.020 |
Why?
| | Blood-Brain Barrier | 1 | 2011 | 106 | 0.020 |
Why?
| | Ultrasonography, Doppler | 1 | 2011 | 105 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2013 | 924 | 0.020 |
Why?
| | Confidence Intervals | 1 | 2011 | 309 | 0.020 |
Why?
| | Pregnancy Proteins | 1 | 2010 | 36 | 0.020 |
Why?
| | Headache | 1 | 2011 | 131 | 0.020 |
Why?
| | Renin-Angiotensin System | 1 | 2010 | 72 | 0.020 |
Why?
| | Vascular Endothelial Growth Factor Receptor-1 | 1 | 2010 | 68 | 0.020 |
Why?
| | Anthropology, Physical | 1 | 2009 | 28 | 0.020 |
Why?
| | Interleukin-4 | 1 | 2010 | 209 | 0.020 |
Why?
| | DNA Copy Number Variations | 1 | 2010 | 156 | 0.020 |
Why?
| | Interleukin 1 Receptor Antagonist Protein | 1 | 2010 | 254 | 0.020 |
Why?
| | Cross-Over Studies | 1 | 2011 | 435 | 0.020 |
Why?
| | Pedigree | 1 | 2010 | 468 | 0.020 |
Why?
| | Chi-Square Distribution | 1 | 2010 | 501 | 0.020 |
Why?
| | Anticonvulsants | 1 | 2011 | 181 | 0.020 |
Why?
| | Fetus | 1 | 2013 | 702 | 0.020 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2010 | 249 | 0.020 |
Why?
| | Up-Regulation | 1 | 2011 | 820 | 0.020 |
Why?
| | Interleukin-10 | 1 | 2010 | 299 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2011 | 573 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2014 | 1310 | 0.020 |
Why?
| | Analysis of Variance | 1 | 2011 | 1230 | 0.020 |
Why?
| | Biological Transport | 1 | 2009 | 375 | 0.020 |
Why?
| | Anti-Inflammatory Agents | 1 | 2011 | 448 | 0.020 |
Why?
| | Head | 1 | 2008 | 86 | 0.020 |
Why?
| | Premature Birth | 1 | 2011 | 278 | 0.020 |
Why?
| | Oxidative Stress | 1 | 2013 | 1093 | 0.020 |
Why?
| | Femur | 1 | 2008 | 194 | 0.020 |
Why?
| | Urban Health | 1 | 2007 | 75 | 0.020 |
Why?
| | Phylogeny | 1 | 2010 | 805 | 0.020 |
Why?
| | Parity | 1 | 2007 | 99 | 0.020 |
Why?
| | Health Status | 1 | 2011 | 728 | 0.020 |
Why?
| | Pregnancy Complications, Cardiovascular | 1 | 2007 | 64 | 0.020 |
Why?
| | Interleukin-6 | 1 | 2010 | 677 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2013 | 2420 | 0.020 |
Why?
| | Hemodynamics | 1 | 2011 | 1024 | 0.020 |
Why?
| | Respiratory Distress Syndrome, Newborn | 1 | 2007 | 102 | 0.020 |
Why?
| | Regression Analysis | 1 | 2008 | 959 | 0.020 |
Why?
| | Mental Health | 1 | 2011 | 571 | 0.020 |
Why?
| | Tumor Necrosis Factor-alpha | 1 | 2010 | 1137 | 0.020 |
Why?
| | Age Factors | 1 | 2011 | 2911 | 0.010 |
Why?
| | Genome-Wide Association Study | 1 | 2009 | 1218 | 0.010 |
Why?
| | Body Weight | 1 | 2007 | 867 | 0.010 |
Why?
| | Male | 3 | 2013 | 56050 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 2129 | 0.010 |
Why?
| | Cohort Studies | 1 | 2011 | 4949 | 0.010 |
Why?
| | Infant | 1 | 2014 | 7979 | 0.010 |
Why?
| | Risk Assessment | 1 | 2010 | 2990 | 0.010 |
Why?
| | Surveys and Questionnaires | 1 | 2011 | 4669 | 0.010 |
Why?
| | Treatment Outcome | 1 | 2011 | 9162 | 0.010 |
Why?
| | Risk Factors | 1 | 2010 | 8702 | 0.010 |
Why?
| | Child | 1 | 2011 | 18503 | 0.010 |
Why?
|
|
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|